Academic Freedom in Clinical Research
- 24 October 2002
- journal article
- other
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 347 (17) , 1368-1371
- https://doi.org/10.1056/nejmsb020394
Abstract
“Is the university–industrial complex out of control?” The editorial that appeared under this eye-catching title in Nature in January 2001 came to the conclusion that links between academia and industry are of increasing concern to academics and to society at large and that the sectors involved must review and revise their policies in order to sustain the public accountability and academic freedom of universities.1 It ended with a list of New Year's resolutions for actions that would be required to maintain public trust in higher education and publicly funded research. But with the notable exception of the decision of many . . .Keywords
This publication has 23 references indexed in Scilit:
- A postmodern moral tale: the ethics of research relationshipsNature Reviews Drug Discovery, 2002
- Sponsorship, Authorship, and AccountabilityNew England Journal of Medicine, 2001
- Oral iron chelation therapy for thalassaemia: an uncertain scene. AnnotationBritish Journal of Haematology, 2000
- Factors Influencing Effectiveness of Deferiprone in a Thalassaemia major Clinical SettingActa Haematologica, 2000
- Thyroid stormPublished by American Medical Association (AMA) ,1997
- Efficacy of Deferoxamine in Preventing Complications of Iron Overload in Patients with Thalassemia MajorNew England Journal of Medicine, 1994
- The Development of Hydroxypyridin‐4‐ones as Orally Active Iron ChelatorsAnnals of the New York Academy of Sciences, 1990
- Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.BMJ, 1987
- Prevention of Cardiac Disease by Subcutaneous Deferoxamine in Patients with Thalassemia MajorNew England Journal of Medicine, 1985
- Serum ferritin in children with thalassaemia regularly transfusedJournal of Clinical Pathology, 1974